| Preparation and preclinical evaluation of inhalable particles containing rapamycin and anti-tuberculosis agents for induction of autophagy A Gupta, D Sharma, J Meena, S Pandya, M Sachan, S Kumar, K Singh, ... Pharmaceutical research 33, 1899-1912, 2016 | 43 | 2016 |
| Coxiella burnetii and Related Tick Endosymbionts Evolved from Pathogenic Ancestors AE Brenner, S Muñoz-Leal, M Sachan, MB Labruna, R Raghavan Genome biology and evolution 13 (7), evab108, 2021 | 37 | 2021 |
| Opportunities and challenges for host-directed therapies in tuberculosis M Sachan, A Srivastava, R Ranjan, A Gupta, S Pandya, A Misra Current Pharmaceutical Design 22 (17), 2599-2604, 2016 | 33 | 2016 |
| KLF10 deficiency in CD4+ T cells promotes atherosclerosis progression by altering macrophage dynamics AK Wara, S Rawal, X Yang, D Pérez-Cremades, M Sachan, J Chen, ... Atherosclerosis 359, 27-41, 2022 | 5 | 2022 |
| Ticks convert pathogenic Coxiella into endosymbionts AE Brenner, S Muñoz-Leal, M Sachan, MB Labruna, R Raghavan bioRxiv, 2020.12. 29.424491, 2020 | 4 | 2020 |
| miR-369-3p ameliorates diabetes-associated atherosclerosis by regulating macrophage succinate-GPR91 signaling S Rawal, V Randhawa, SHM Rizvi, M Sachan, AK Wara, ... Cardiovascular Research, cvae102, 2024 | 1 | 2024 |
| A miRNA cassette reprograms smooth muscle cells into endothelial cells MG McCoy, D Pérez‐Cremades, N Belkin, W Peng, B Zhang, J Chen, ... The FASEB Journal 36 (4), e22239, 2022 | 1 | 2022 |
| Inhaled drug combinations S Pandya, A Gupta, R Ranjan, M Sachan, AK Agrawal, A Misra Drug Delivery Systems for Tuberculosis Prevention and Treatment, 213-238, 2016 | 1 | 2016 |
| Therapeutic Delivery Of MICRORNA-369-3p Promotes Atherosclerosis Regression In Diabetic Mice By Regulating Bone Marrow Myeloid Progenitors S Rawal, AK Wara, M Sachan, C de Oliveira Vaz, V Randhawa, ... Arteriosclerosis, Thrombosis, and Vascular Biology 44 (Suppl_1), A2059-A2059, 2024 | | 2024 |
| MicroRNA-1282 As A Cis-Antisense Regulator Of Angiogenesis In Diabetic Critical Limb Ischemia M Sachan, S Rawal, W Wu, C Vaz, M McCoy, H Cheng, ... Arteriosclerosis, Thrombosis, and Vascular Biology 43 (Suppl_1), A546-A546, 2023 | | 2023 |
| MicroRNAs Contribute to Host Response to Coxiella burnetii M Sachan, KR Brann, MS Fullerton, DE Voth, R Raghavan Infection and Immunity 91 (1), e00199-22, 2023 | | 2023 |
| Regulation of Succinate Signaling and Immunometabolism in Diabetes-Associated Atherosclerosis by Microrna-369-3p S Rawal, SHM Rizvi, A Wara, M Sachan, V Randhawa, RM Weisbrod, ... Circulation 146 (Suppl_1), A14672-A14672, 2022 | | 2022 |
| Correction to: Preparation and Preclinical Evaluation of Inhalable Particles Containing Rapamycin and Anti-Tuberculosis Agents for Induction of Autophagy A Gupta, D Sharma, J Meena, S Pandya, M Sachan, S Kuma, K Singh, ... Pharmaceutical Research 39 (5), 1027-1028, 2022 | | 2022 |
| Exploring miRNA Function and Host Response to Coxiella burnetii Infection M Sachan Portland State University, 2021 | | 2021 |
| Antimicrobial Resistance: A Broken R&D System Shares The Blame M Sachan, I Katariya https://www.huffpost.com/archive/in/entry/antimicrobial-resistance-a-broken …, 2017 | | 2017 |
| Laboratory and non-clinical evaluation of pulmonary drug delivery in TB AM Sanketkumar Pandya, Rajeev Gupta, Anuradha, Ranjan, Madhur Sachan, Ashish ... The International Journal of Tuberculosis and Lung Disease, S151-S1, 2015 | | 2015 |
| Under-engineering a DPI Device for Tuberculosis Treatment: Facilitating Access to Inhaled Therapies among Disadvantaged Groups in India AM Rajeev Ranjan, Sanketkumar Pandya, Anuradha Gupta, Madhur Sachan, Kajal ... RDD Asia (RDD Online), 67-74, 2014 | | 2014 |
